Name changes in medically important fungi and their implications for clinical practice

G. Sybren De Hoog, Vishnu Chaturvedi, David W. Denning, Paul S. Dyer, Jens Christian Frisvad, David Geiser, Yvonne Gräser, Josep Guarro, Gerhard Haase, Kyung Joo Kwon-Chung, Jacques F. Meis, Wieland Meyer, John I. Pitt, Robert A. Samson, John W. Taylor, Kathrin Tintelnot, Roxana G. Vitale, Thomas J. Walsh, Michaela Lackner, Teun BoekhoutArunaloke Chakrabarti, Anuradha Chowdhary, Garry Cole, Olivier A. Cornely, Pedro W. Crous, Christophe D'Enfert, Dea Garcia-Hermoso, D. David Ellis, Cornelia Lass-Flörl, Stuart Levitz, Ruo Yu Li, Aaron P. Mitchell, Kerry O'Donnell, John R. Perfect, Flavio Queiroz Telles, Deanna A. Sutton, Kerstin Voigt, Theodore C. White, Liyan Xi

Research output: Contribution to journalComment/debatepeer-review

Abstract

Recent changes in the Fungal Code of Nomenclature and developments in molecular phylogeny are about to lead to dramatic changes in the naming of medically important molds and yeasts. In this article, we present a widely supported and simple proposal to prevent unnecessary nomenclatural instability.

Original languageEnglish (US)
Pages (from-to)1056-1062
Number of pages7
JournalJournal of clinical microbiology
Volume53
Issue number4
DOIs
StatePublished - Apr 1 2015

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Name changes in medically important fungi and their implications for clinical practice'. Together they form a unique fingerprint.

Cite this